What is the ticker symbol for Allarity Therapeutics?

Allarity Therapeutics trades under the ticker ALLR on NASDAQ.

What sector does Allarity Therapeutics operate in?

Allarity Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze ALLR in a portfolio?

PortView shows ALLR's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Allarity Therapeutics (ALLR) Stock Analysis

NASDAQHealthcareBiotechnology

$1.42-0.35%

1-year price historyRange $0.81 – $1.97

52-week range$1.42

$0.77$2.06

What Allarity Therapeutics does

Allarity Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new cancer treatments. They utilize a unique "drug response predictor" technology to generate specific companion diagnostics, aiming to identify which patients will best respond to their various oncology therapeutics. The company's portfolio of investigational drugs for various cancers includes: Stenoparib: A poly-ADP-ribose polymerase (PARP) inhibitor currently in Phase 2 clinical trials for ovarian cancer. Dovitinib: A pan-tyrosine kinase inhibitor designed to treat renal cell carcinoma. IXEMPRA: A microtubule inhibitor used in the treatment of metastatic breast cancer. LiPlaCis: A liposomal formulation of cisplatin, undergoing Phase 2 clinical trials for metastatic breast cancer. 2X-111: A liposomal formulation of doxorubicin, also in Phase 2 studies for both metastatic breast cancer and glioblastoma multiforme. Established in 2004, Allarity Therapeutics maintains its headquarters in Cambridge, Massachusetts.

Key metrics

Market cap

$22.51M

P/E (TTM)

-1.86

EPS (TTM)

$-0.76

Beta

0.51

Dividend yield

0.00%

Revenue / share

$0.02

50-day avg

$1.29

200-day avg

$1.24

52-week high

$2.06

52-week low

$0.77

CEO

Thomas H. Jensen

ETFs linked to ALLR

Broad-market and Healthcare sector ETFs an investor holding Allarity Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how ALLR fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ALLR in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Allarity Therapeutics?: Allarity Therapeutics trades under the ticker ALLR on NASDAQ.
Which exchange is ALLR listed on?: ALLR is listed on NASDAQ.
What sector does Allarity Therapeutics operate in?: Allarity Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze ALLR in a portfolio?: PortView shows ALLR's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.